Page last updated: 2024-08-26

1,4-dihydropyridine and Obesity

1,4-dihydropyridine has been researched along with Obesity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berenshteĭn, NV; Burmistrova, LF; Iskenderov, BG; Lokhina, TV1

Trials

1 trial(s) available for 1,4-dihydropyridine and Obesity

ArticleYear
[Hypotensive efficacy and tolerability of combination of dihydropyridine and non-dihydropyridine calcium antagonists in the treatment of patients with arterial hypertension].
    Kardiologiia, 2007, Volume: 47, Issue:11

    Topics: Adult; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Nifedipine; Obesity; Treatment Outcome; Verapamil

2007